Literature DB >> 20648000

MAPK signal-integrating kinase controls cap-independent translation and cell type-specific cytotoxicity of an oncolytic poliovirus.

Christian Goetz1, Richard G Everson, Linda C Zhang, Matthias Gromeier.   

Abstract

Many animal viruses exhibit proficient growth in transformed cells, a property that has been harnessed for the development of novel therapies against cancer. Despite overwhelming evidence for this phenomenon, understanding of the molecular mechanisms enabling tumor-cell killing is rudimentary for most viruses. We report here that growth and cytotoxicity of the prototype oncolytic poliovirus (PV), PVSRIPO, in glioblastoma multiforme (GBM) is promoted by mitogen-activated protein kinases (MAPKs) converging on the MAPK signal-integrating kinase 1 (Mnk1) and its primary substrate, the eukaryotic initiation factor (eIF) 4E. Inducing Mnk1-catalyzed eIF4E phosphorylation through expression of oncogenic Ras substantially enhanced PVSRIPO translation, replication, and cytotoxicity in resistant cells. This effect was mimicked by expression of constitutively active forms of Mnk1 and correlated with enhanced translation of subgenomic reporter RNAs. Our findings implicate Mnk1 activity in stimulation of PVSRIPO cap-independent translation, an effect that can be synergistically enhanced by inhibition of the phosphoinositide-3 kinase (PI3K).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20648000      PMCID: PMC2990508          DOI: 10.1038/mt.2010.145

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  43 in total

1.  A polypeptide in eukaryotic initiation factors that crosslinks specifically to the 5'-terminal cap in mRNA.

Authors:  N Sonenberg; M A Morgan; W C Merrick; A J Shatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2.

Authors:  U Knauf; C Tschopp; H Gram
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

3.  Phosphorylation of eukaryotic initiation factor 4E markedly reduces its affinity for capped mRNA.

Authors:  Gert C Scheper; Barbara van Kollenburg; Jianzhong Hu; Yunjing Luo; Dixie J Goss; Christopher G Proud
Journal:  J Biol Chem       Date:  2001-11-26       Impact factor: 5.157

4.  Chromatographic resolution of in vivo phosphorylated and nonphosphorylated eukaryotic translation initiation factor eIF-4E: increased cap affinity of the phosphorylated form.

Authors:  W B Minich; M L Balasta; D J Goss; R E Rhoads
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

5.  The 5' end of poliovirus mRNA is not capped with m7G(5')ppp(5')Np.

Authors:  A Nomoto; Y F Lee; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

6.  Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development.

Authors:  Takeshi Ueda; Rie Watanabe-Fukunaga; Hidehiro Fukuyama; Shigekazu Nagata; Rikiro Fukunaga
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

7.  Phosphorylation of eIF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells.

Authors:  Derek Walsh; Ian Mohr
Journal:  Genes Dev       Date:  2004-03-15       Impact factor: 11.361

8.  Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002.

Authors:  Anjali K Gupta; George J Cerniglia; Rosemarie Mick; Mona S Ahmed; Vincent J Bakanauskas; Ruth J Muschel; W Gillies McKenna
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-07-01       Impact factor: 7.038

9.  Cleavage of poly(A)-binding protein by poliovirus 3C protease inhibits host cell translation: a novel mechanism for host translation shutoff.

Authors:  N Muge Kuyumcu-Martinez; Marc E Van Eden; Patrick Younan; Richard E Lloyd
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

10.  Combinatorial efficacy achieved through two-point blockade within a signaling pathway-a chemical genetic approach.

Authors:  Qi-Wen Fan; Kimberly Musa Specht; Chao Zhang; Dmitriy D Goldenberg; Kevan M Shokat; William A Weiss
Journal:  Cancer Res       Date:  2003-12-15       Impact factor: 12.701

View more
  25 in total

Review 1.  Oncolytic viruses: From bench to bedside with a focus on safety.

Authors:  Pascal R A Buijs; Judith H E Verhagen; Casper H J van Eijck; Bernadette G van den Hoogen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  Tinkering with translation: protein synthesis in virus-infected cells.

Authors:  Derek Walsh; Michael B Mathews; Ian Mohr
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-01-01       Impact factor: 10.005

3.  A host-specific, temperature-sensitive translation defect determines the attenuation phenotype of a human rhinovirus/poliovirus chimera, PV1(RIPO).

Authors:  Nusrat Jahan; Eckard Wimmer; Steffen Mueller
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

4.  Oncolytic poliovirus against malignant glioma.

Authors:  Christian Goetz; Elena Dobrikova; Mayya Shveygert; Mikhail Dobrikov; Matthias Gromeier
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

5.  Induction of viral, 7-methyl-guanosine cap-independent translation and oncolysis by mitogen-activated protein kinase-interacting kinase-mediated effects on the serine/arginine-rich protein kinase.

Authors:  Michael C Brown; Jeffrey D Bryant; Elena Y Dobrikova; Mayya Shveygert; Shelton S Bradrick; Vidyalakshmi Chandramohan; Darell D Bigner; Matthias Gromeier
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

6.  Oncogenic Ras inhibits IRF1 to promote viral oncolysis.

Authors:  Y Komatsu; S L Christian; N Ho; T Pongnopparat; M Licursi; K Hirasawa
Journal:  Oncogene       Date:  2014-10-27       Impact factor: 9.867

Review 7.  Developing anti-neoplastic biotherapeutics against eIF4F.

Authors:  Jutta Steinberger; Jennifer Chu; Rayelle Itoua Maïga; Katia Sleiman; Jerry Pelletier
Journal:  Cell Mol Life Sci       Date:  2016-12-21       Impact factor: 9.261

Review 8.  Oncolytic immunotherapy through tumor-specific translation and cytotoxicity of poliovirus.

Authors:  Michael C Brown; Matthias Gromeier
Journal:  Discov Med       Date:  2015-05       Impact factor: 2.970

9.  Mitogen-activated protein kinase-interacting kinase regulates mTOR/AKT signaling and controls the serine/arginine-rich protein kinase-responsive type 1 internal ribosome entry site-mediated translation and viral oncolysis.

Authors:  Michael C Brown; Mikhail I Dobrikov; Matthias Gromeier
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

Review 10.  Oncolytic polio virotherapy of cancer.

Authors:  Michael C Brown; Elena Y Dobrikova; Mikhail I Dobrikov; Ross W Walton; Sarah L Gemberling; Smita K Nair; Annick Desjardins; John H Sampson; Henry S Friedman; Allan H Friedman; Douglas S Tyler; Darell D Bigner; Matthias Gromeier
Journal:  Cancer       Date:  2014-06-17       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.